drugset / Trial / NCT06363461
Study of TDM-180935 in Atopic Dermatitis Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
Randomized, Vehicle-controlled, Parallel Group Study of TDM-180935 in Atopic Dermatitis Patients
Timeline
- Start
- 2024-04-13
- Primary completion
- 2025-03-08
- Completion
- 2025-04-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | TDM-180935 | Unknown | 1 % | Topical |
| Subject | TDM-180935 | Unknown | 2 % | Topical |